Home News & Insights Sharp Introduces Plasmacluster Air Purifiers to New Zealand

Sharp Introduces Plasmacluster Air Purifiers to New Zealand

Sharp Corporation of New Zealand, a subsidiary of Sharp Japan is excited to introduce their revolutionary air purifiers arriving into the country this week. Built in with Sharp's patented Plasmacluster ion technology, the air purifiers ensure a clean, well balanced air flow which has been proven to be highly effective against airborne viruses and mould.*

Angela McLachlan, Product Manager for Consumer Electronics says the two models 'Compact FPJ30JB' and 'Comfort FXJ80JW' are perfect for most indoor situations. "Plasmacluster ions are positive and negative ions that occur in nature, and have been proven to be safe to humans no matter the ion concentration. Our purifiers will be a great addition for homes, offices, hotels, aged care and medical facilities."

Sharp air purifiers have a three-step dust collection system that includes a HEPA filter and a deodorizing filter to capture 99.97% of microscopic particles in the air. The FP-series that Sharp is introducing to New Zealand have been tested and approved by the British Allergy Foundation.

"As people start to have more events and businesses going back to usual, it's really important that we take preventative measures. We think one way is using proven technology to ensure the air we're breathing in is clean and safe," says Angela McLachlan.

Since the introduction of the first air purifiers equipped with Plasmacluster in 2000, Sharp has sold over 100 million units equipped with Plasmacluster Ion technology worldwide. View the new range here.

*Study on Plasmascluster technology:
In October 2022, Sharp announced two study reports on Plasmacluster efficacy by collaboration with a world-renowned institute, Columbia University in the United States.

1. World first report: Plasmacluster Technology Demonstrates Effectiveness in Reducing Airborne Novel Coronavirus (SARS-CoV-2 Omicron BA.1 Variant)
Validated at Columbia University Irving Medical Center, USA

2. World's first report: The potential effect of Plasmacluster Technology on reducing viscous airway mucus that may relieve asthma symptoms using airway stem cell culture
Validated at Columbia University Irving Medical Center, USA